Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
15.01
+0.36 (2.46%)
At close: May 12, 2025, 4:00 PM
14.55
-0.46 (-3.06%)
After-hours: May 12, 2025, 6:16 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $973.79 million as of May 12, 2025. Its market cap has increased by 72.72% in one year.
Market Cap
973.79M
Enterprise Value
769.77M
1-Year Change
72.72%
Ranking
Category
Stock Price
$15.01
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $973.79M, an increase of 55.83%. That is a compound annual growth rate of 21.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 950.44M | 55.13% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.87B |
| Johnson & Johnson | 370.90B |
| UnitedHealth Group | 343.41B |
| AbbVie | 335.67B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.47B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |